Beximco launches world’s first oral antiviral drug for COVID-19 treatment
LONDON, UK: Beximco Pharmaceuticals Limited announced the launch of the world’s first generic molnupiravir, an oral antiviral drug for symptomatic COVID-19 recently developed by Merck,...
Beximco completes £39.35 million acquisition of Sanofi Bangladesh
LONDON, UK: Beximco Pharmaceuticals Limited has now completed its acquisition of the majority stake in Sanofi Bangladesh Limited, first announced on 21 January 2021. The...